Advertisement

CHEST 2026


  • 25 years of CHEST Challenge: Catching up with former finalists

    25 years of CHEST Challenge: Catching up with former finalists

    Ahead of the 25th annual CHEST Challenge Championship in Phoenix, finalists from different eras share their memories from participating and the lasting impact it had on their careers.


  • Session to explore how biologics and antialarmins are changing the COPD landscape

    Session to explore how biologics and antialarmins are changing the COPD landscape

    Biologics and antialarmins are rewriting the playbook for COPD treatment and opening the field to more targeted therapies and precision medicine, said Sara Assaf, MD.


  • Experts to highlight pneumothorax best practices, real-world troubleshooting

    Experts to highlight pneumothorax best practices, real-world troubleshooting

    The session will guide attendees through complex pneumothorax decision-making and explore cases from the audience, said Laura Kathleen Frye, MD, FCCP.



  • Chest infections and disaster response at CHEST 2026: Updates on community-acquired pneumonia and more

    Chest infections and disaster response at CHEST 2026: Updates on community-acquired pneumonia and more

    Other major topics of discussion will include endemic infections, rare-but-deadly pulmonary pathogens, and changes in vaccine policy, said Ryan Maves, MD, FCCP.


  • Sleep medicine at CHEST 2026: Fresh look at GLP-1 drugs for OSA

    Sleep medicine at CHEST 2026: Fresh look at GLP-1 drugs for OSA

    Sessions will look at new information about patients who are receiving glucagon-like peptide-1 (GLP-1) medications and how that affects their sleep-disordered breathing, said Sherri Katz, MD, FCCP.


  • Explore enlightening abstracts and case reports at CHEST 2026

    Explore enlightening abstracts and case reports at CHEST 2026

    Thousands of oral, rapid-fire, and poster presentations will reveal novel findings, showcase fresh perspectives, spark exciting collaborations, and potentially even shape the future of pulmonary, critical care, and sleep medicine.


  • Experts to share updates in diagnosis, care of alpha-1 antitrypsin deficiency

    Experts to share updates in diagnosis, care of alpha-1 antitrypsin deficiency

    Emerging diagnostic algorithms and advances in therapy could transform management of alpha-1 antitrypsin deficiency, an often-overlooked genetic disease that affects the lungs and the liver, said Malik Khurram Khan, MD, FCCP.


  • Clinicians to explore timely recognition, treatment of autoimmune crises in ICU

    Clinicians to explore timely recognition, treatment of autoimmune crises in ICU

    Rheumatologic diseases can be difficult to recognize when encountered in the ICU. Missing these diagnoses can delay life-saving therapies and significantly impact patients’ outcomes, said Rami Batarseh, MD, FCCP.



  • Featured speakers to share insights from impactful chest medicine careers

    Featured speakers to share insights from impactful chest medicine careers

    CHEST 2026 Honor and Memorial Lectures will recognize individuals who have advanced work in critical care, interventional medicine, mechanical ventilation, medical education, and other areas.


  • Thoracic oncology at CHEST 2026: Breaking down guidelines, AI, and gray zones for all experts

    Thoracic oncology at CHEST 2026: Breaking down guidelines, AI, and gray zones for all experts

    Sessions spanning lung cancer diagnosis, interventional pulmonology, and radiology will reflect the fast-moving field and the real-world questions clinicians face every day in practice, said Jose De Cardenas, MD, FCCP.